{"id":675522,"date":"2026-03-23T07:43:13","date_gmt":"2026-03-23T07:43:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/675522\/"},"modified":"2026-03-23T07:43:13","modified_gmt":"2026-03-23T07:43:13","slug":"the-cutthroat-battle-for-the-us-weight-loss-drug-market-bbc","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/675522\/","title":{"rendered":"The cutthroat battle for the US weight-loss drug market – BBC"},"content":{"rendered":"
    \n
  1. The cutthroat battle for the US weight-loss drug market<\/a>  BBC<\/li>\n
  2. FDA Approves New High-Dose Wegovy in US For Boosted Weight Loss<\/a>  ScienceAlert<\/li>\n
  3. FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share<\/a>  CNBC<\/li>\n
  4. Novo uses FDA voucher to win speedy approval of higher-dose Wegovy<\/a>  BioPharma Dive<\/li>\n
  5. Weight-loss treatment is on the verge of a dramatic shift \u2013 again<\/a>  CNN<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"The cutthroat battle for the US weight-loss drug market  BBC FDA Approves New High-Dose Wegovy in US For Boosted…\n","protected":false},"author":3,"featured_media":675523,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[210,1060,67,132,68],"class_list":{"0":"post-675522","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116277373085563415","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/675522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=675522"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/675522\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/675523"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=675522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=675522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=675522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}